FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W112660232> ?p ?o ?g. }

• W112660232 abstract "In critically ill patients, the pathophysiology of sepsis can affect the interactions between the antibiotic, the bacteria and the patient, leading to potential therapeutic failure and the development of antibiotic resistance. It is well acknowledged that research that optimises antibiotic exposure will assist improvement of outcomes in this patient group. Although beta-lactam antibiotics, such as piperacillin and meropenem, are commonly selected for empiric therapy of sepsis, dosing is unlikely to be optimal. In patients without renal dysfunction, data suggests that disease-induced alterations to pharmacokinetic parameters result in low trough concentrations for significant periods within a dosing interval. Administration of these time-dependent antibiotics by continuous infusion has been suggested to improve the pharmacokinetic-pharmacodynamic profile. Knowledge of concentrations in the extracellular fluid of human tissue, which is the target site of most pathogens, is particularly instructive. Extracellular fluid concentrations can be determined using techniques such as microdialysis. Therefore, the principal aims of this Thesis were to determine the plasma and subcutaneous tissue pharmacokinetics of piperacillin and meropenem administered by bolus dosing and continuous infusion in critically ill patients with sepsis; and to use Monte Carlo simulations to compare the ability of different dosing strategies to achieve pharmacodynamic endpoints. This Thesis also sought to compare the clinical outcomes of bolus dosing and continuous infusion of a beta-lactam antibiotic, ceftriaxone, in a prospective randomised controlled trial and to perform a meta-analysis on clinical outcomes from other similar published studies. Finally, this Thesis aimed to systematically review the published literature to determine any correlation between antibiotic dosing and the development of antibiotic resistance. The results of the pharmacokinetic studies, using piperacillin and meropenem, indicate that beta-lactam distribution into subcutaneous tissue, in critically ill patients with sepsis, is less than that observed in previous studies in healthy volunteers yet superior to studies in patients with septic shock. This supports the notion that the peripheral concentration of drugs may be inversely related to the level of sickness severity. Administration by continuous infusion was found to maintain statistically significantly higher trough beta-lactam concentrations in both plasma and subcutaneous tissue. Further analysis of the plasma data using population pharmacokinetic modeling and Monte Carlo simulations described significant pharmacodynamic advantages for administering meropenem or piperacillin by continuous infusion to organisms with high minimum inhibitory concentrations. Given the documented pharmacodynamic advantages for administering beta-lactams by continuous infusion, a prospective randomized controlled clinical trial was conducted using the beta-lactam antibiotic ceftriaxone. In 57 critically ill patients, we found equivalence between continuous infusion and bolus dosing in the intention-to-treat analysis. However, our a priori analysis criteria, requiring patients receive at least 4-days antibiotic treatment, found significant clinical and bacteriological advantages for administration by continuous infusion. To further investigate any clinical differences between bolus dosing and continuous infusion of beta-lactam antibiotics, we performed a meta-analysis of all published studies. Our analysis of the 13 published prospective randomized controlled trials (846 hospitalised patients) showed equivalence of continuous infusion and bolus dosing. Possible confounders observed within, and between the studies, make interpretation of these results challenging. However, two large retrospective cohorts not included in the meta-analysis, found definitive clinical and bacteriological advantages suggesting further research may be appropriate. The possible relationship between antibiotic dosing, or exposures, on the development of resistance was investigated using a structured review of the published literature. Our analysis of relevant papers found a wealth of data describing increasing levels of resistance with sub-optimal antibiotic dosing, particularly for fluoroquinolone antibiotics, but also for other classes including beta-lactams. These results demonstrate the importance of optimizing antibiotic dosing to decrease the development of antibiotic susceptibility from sub-optimal dosing, particularly for critically ill patients who are likely to have low drug concentrations. The results of this Thesis, suggest that a large, prospective, multi-centre randomised controlled trial in critically ill patients with sepsis, is required to definitively determine the clinical utility of administration of beta-lactam antibiotics by continuous infusion." @default.
• W112660232 created "2016-06-24" @default.
• W112660232 creator A5063546488 @default.
• W112660232 date "2008-09-01" @default.
• W112660232 modified "2023-09-27" @default.
• W112660232 title "Beta-lactam antibiotic dosing in critical care units: bolus vs continuous dosing" @default.
• W112660232 hasPublicationYear "2008" @default.
• W112660232 type Work @default.
• W112660232 sameAs 112660232 @default.
• W112660232 citedByCount "0" @default.
• W112660232 crossrefType "journal-article" @default.
• W112660232 hasAuthorship W112660232A5063546488 @default.
• W112660232 hasConcept C111113717 @default.
• W112660232 hasConcept C112705442 @default.
• W112660232 hasConcept C126322002 @default.
• W112660232 hasConcept C177713679 @default.
• W112660232 hasConcept C2777288759 @default.
• W112660232 hasConcept C2777637488 @default.
• W112660232 hasConcept C2778193466 @default.
• W112660232 hasConcept C2778384902 @default.
• W112660232 hasConcept C2779375183 @default.
• W112660232 hasConcept C2987404301 @default.
• W112660232 hasConcept C43376680 @default.
• W112660232 hasConcept C501593827 @default.
• W112660232 hasConcept C523546767 @default.
• W112660232 hasConcept C54355233 @default.
• W112660232 hasConcept C71924100 @default.
• W112660232 hasConcept C86803240 @default.
• W112660232 hasConcept C89423630 @default.
• W112660232 hasConcept C94665300 @default.
• W112660232 hasConcept C98274493 @default.
• W112660232 hasConceptScore W112660232C111113717 @default.
• W112660232 hasConceptScore W112660232C112705442 @default.
• W112660232 hasConceptScore W112660232C126322002 @default.
• W112660232 hasConceptScore W112660232C177713679 @default.
• W112660232 hasConceptScore W112660232C2777288759 @default.
• W112660232 hasConceptScore W112660232C2777637488 @default.
• W112660232 hasConceptScore W112660232C2778193466 @default.
• W112660232 hasConceptScore W112660232C2778384902 @default.
• W112660232 hasConceptScore W112660232C2779375183 @default.
• W112660232 hasConceptScore W112660232C2987404301 @default.
• W112660232 hasConceptScore W112660232C43376680 @default.
• W112660232 hasConceptScore W112660232C501593827 @default.
• W112660232 hasConceptScore W112660232C523546767 @default.
• W112660232 hasConceptScore W112660232C54355233 @default.
• W112660232 hasConceptScore W112660232C71924100 @default.
• W112660232 hasConceptScore W112660232C86803240 @default.
• W112660232 hasConceptScore W112660232C89423630 @default.
• W112660232 hasConceptScore W112660232C94665300 @default.
• W112660232 hasConceptScore W112660232C98274493 @default.
• W112660232 hasLocation W1126602321 @default.
• W112660232 hasOpenAccess W112660232 @default.
• W112660232 hasPrimaryLocation W1126602321 @default.
• W112660232 hasRelatedWork W1503187888 @default.
• W112660232 hasRelatedWork W1981568603 @default.
• W112660232 hasRelatedWork W2004888852 @default.
• W112660232 hasRelatedWork W2016888150 @default.
• W112660232 hasRelatedWork W2034971091 @default.
• W112660232 hasRelatedWork W2124431328 @default.
• W112660232 hasRelatedWork W2153171442 @default.
• W112660232 hasRelatedWork W2230341374 @default.
• W112660232 hasRelatedWork W2383076799 @default.
• W112660232 hasRelatedWork W2465450710 @default.
• W112660232 hasRelatedWork W2778135811 @default.
• W112660232 hasRelatedWork W2793243681 @default.
• W112660232 hasRelatedWork W2810311913 @default.
• W112660232 hasRelatedWork W2944127871 @default.
• W112660232 hasRelatedWork W2971405876 @default.
• W112660232 hasRelatedWork W2974202286 @default.
• W112660232 hasRelatedWork W3142162413 @default.
• W112660232 hasRelatedWork W3170870696 @default.
• W112660232 hasRelatedWork W3196712200 @default.
• W112660232 hasRelatedWork W754245352 @default.
• W112660232 isParatext "false" @default.
• W112660232 isRetracted "false" @default.
• W112660232 magId "112660232" @default.
• W112660232 workType "article" @default.